NeuroPace, Inc.
NPCE
$8.42
-$0.14-1.64%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 23.32% | 22.05% | 22.14% | 27.00% | 30.75% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 23.32% | 22.05% | 22.14% | 27.00% | 30.75% |
Cost of Revenue | 15.75% | 18.03% | 20.36% | 18.98% | 17.37% |
Gross Profit | 25.96% | 23.47% | 22.78% | 30.11% | 36.16% |
SG&A Expenses | 8.66% | 1.52% | 4.74% | 3.02% | 3.65% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 12.26% | 8.49% | 9.70% | 7.96% | 5.96% |
Operating Income | 19.81% | 27.00% | 20.25% | 27.87% | 31.62% |
Income Before Tax | 13.23% | 21.27% | 17.64% | 25.89% | 29.54% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 13.23% | 21.27% | 17.64% | 25.89% | 29.54% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 13.23% | 21.27% | 17.64% | 25.89% | 29.54% |
EBIT | 19.81% | 27.00% | 20.25% | 27.87% | 31.62% |
EBITDA | 20.08% | 27.33% | 20.51% | 28.07% | 31.71% |
EPS Basic | 23.29% | 29.86% | 26.93% | 33.81% | 36.00% |
Normalized Basic EPS | 21.74% | 28.50% | 25.65% | 33.97% | 36.16% |
EPS Diluted | 23.29% | 29.86% | 26.93% | 33.81% | 36.00% |
Normalized Diluted EPS | 21.74% | 28.50% | 25.65% | 33.97% | 36.16% |
Average Basic Shares Outstanding | 12.50% | 12.31% | 12.68% | 11.79% | 9.81% |
Average Diluted Shares Outstanding | 12.50% | 12.31% | 12.68% | 11.79% | 9.81% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |